Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Botulinum Toxin Versus Mesotherapy on Enhancement of Facial Scarring (A Randomized Controlled Clinical Trial)

NCT06562023 is registered in ClinicalTrials.gov with Hams Hamed Abdelrahman as lead sponsor.

NCT NCT06562023
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06562023 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Botulinum Toxin Versus Mesotherapy on Enhancement of Facial Scarring (A Randomized Controlled Clinical Trial)
Lead sponsor
Hams Hamed Abdelrahman
Phase
Not applicable
Overall status
Completed
Start date
November 19, 2022
Completion date
July 20, 2024
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

facial scars